Fortress Biotech
FBIO
39 hedge funds and large institutions have $18.6M invested in Fortress Biotech in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 41 → 39 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
35% less capital invested
Capital invested by funds: $28.5M → $18.6M (-$9.92M)
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $12K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$1.08M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$687K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$126K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$56.4K |
| 5 |
Millennium Management
New York
|
+$50.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
-$3.56M |
| 2 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$565K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$379K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$335K |
| 5 |
Goldman Sachs
New York
|
-$280K |
FBIO Hedge Fund Activity: Q3 2015 in Review
39 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2015, worth a combined $18.6M — down 35% from $28.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FBIO and 6 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 8 added.
The largest buyer was Avoro Capital Advisors, adding an estimated $1.08M. The largest seller was Elliott Management, cutting an estimated $3.56M.
- 39 institutional investors held Fortress Biotech (FBIO) as of Q3 2015, down from 41 in Q2 2015.
- Funds reported $18.6M of Fortress Biotech stock for Q3 2015, down 35% quarter-over-quarter.
- 6 funds opened new Fortress Biotech positions in Q3 2015 and 8 closed out, a net change of -2 holders.
- The largest Fortress Biotech buyer in Q3 2015 was Avoro Capital Advisors, an estimated $1.08M added.
- The largest Fortress Biotech seller in Q3 2015 was Elliott Management, an estimated $3.56M sold.
Based on aggregated 13F filings for Q3 2015.